Subscribe To
SXTP / 60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
SXTP News
By GlobeNewsWire
October 19, 2023
60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
60 Degrees Pharma Presents Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meetin more_horizontal
By GlobeNewsWire
September 6, 2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference
WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical comp more_horizontal
By InvestorPlace
July 13, 2023
Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 17% Today?
60 Degrees Pharmaceuticals (NASDAQ: SXTP ) stock is on the rise Thursday following the company's public debut yesterday. The public launch of SXTP sto more_horizontal